Newswires
Submission of Matters to a Vote of Security Holders – Form 8-K
tndm-20230524
UNITED STATES
Washington, D.C. 20549
Tandem Diabetes Care, Inc.
SECURITIES AND EXCHANGE COMMISSION
____________________________
FORM 8-K
____________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 24, 2023
____________________________
(Exact name of registrant as specified in its charter)
_________
| 001-36189 | 20-4327508 | |
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
| 92130 | ||
| ( |
||
| (Address of principal executive offices) |
Registrant's telephone number, including area code: (858) 366-6900
N/A
(Former name or former address, if changed since last report)
____________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
| Title of Each Class | Symbol | |
| Common Stock, par value |
TNDM | Nasdaq Global Market |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐
___________________________
Item 5.07 Submission of Matters to a Vote of Security Holders.
On May 24, 2023 , Tandem Diabetes Care, Inc. (the "Company") held a virtual Annual Meeting of Stockholders (the "Annual Meeting"). There were 64,606,732 shares of the Company's common stock ("Common Stock") outstanding on March 28, 2023 , the record date for the Annual Meeting. At the Annual Meeting, 58,914,493 shares of Common Stock were present virtually or represented by proxy.
The following tables set forth the final results of the voting for the matters voted upon at the Annual Meeting. These matters are described in more detail in the Company's definitive proxy statement, filed with the Securities and Exchange Commission (the "SEC") on April 12, 2023 (the "Proxy Statement").
Proposal 1: To elect four Class I and three Class III directors for a one-year term expiring at the 2024 annual meeting of stockholders. The stockholders elected four Class I and three Class III directors by the following votes:
| For | Against | Abstain | Broker Non-Votes | |
| 47,663,540 | 8,307,290 | 23,189 | 2,920,474 | |
| Myoungil Cha | 46,739,317 | 9,178,406 | 76,296 | 2,920,474 |
| 46,122,306 | 9,788,662 | 83,051 | 2,920,474 | |
| Joao Paulo Falcao Malagueira | 54,961,819 | 955,155 | 77,045 | 2,920,474 |
| 46,417,748 | 9,501,237 | 75,034 | 2,920,474 | |
| 47,034,251 | 8,936,456 | 23,312 | 2,920,474 | |
| 46,184,111 | 9,732,168 | 77,740 | 2,920,474 |
Proposal 2: To approve the Company's 2023 Long-Term Incentive Plan, which will replace the 2013 Stock Incentive Plan expiring on November 15, 2023 . The proposal received the following votes:
| For | Against | Abstain | Broker Non-Votes |
| 51,791,463 | 4,104,680 | 97,876 | 2,920,474 |
Proposal 3: To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. The proposal received the following votes:
| For | Against | Abstain | Broker Non-Votes |
| 45,684,932 | 10,258,454 | 50,633 | 2,920,474 |
Proposal 4: To ratify of the appointment of Ernst & Young LLP to serve as the Company's independent registered public accountant for the year ending December 31, 2023 . The proposal received the following votes:
| For | Against | Abstain | Broker Non-Votes |
| 58,058,014 | 790,996 | 65,483 |
Item 5.08Shareholder Director Nominations.
A proposal submitted by a stockholder for inclusion in the proxy materials for the Company's 2024 annual meeting of stockholders (the "2024 Annual Meeting"), must be received by the Company's Corporate Secretary at 12400 High Bluff Drive , San Diego, CA 92130 on or before December 14, 2023 and comply with the requirements of Rule 14a-8 of the Exchange Act of 1934, as amended.
In addition, a stockholder who wishes to submit a proposal for consideration at the 2024 Annual Meeting without including that proposal in the proxy materials for that meeting must notify the Company of that proposal no earlier than the close of business on January 25, 2024 , and no later than the close of business on February 24, 2024 . The Company's Amended and Restated Bylaws specify requirements regarding the delivery of any such notice and the inclusion of any such proposal to be considered at the 2024 Annual Meeting.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
By:
|
/s/ |
| Senior Vice President, General Counsel, Corporate Secretary & Chief Compliance Officer |
Date: May 25, 2023
Attachments
Disclaimer
Security Council Urged to Step up On Financing for AU Peace Operations
Merger Agreement – Form 8-K
Advisor News
- Health insurance premium tax bill advancing
- The Medi-Cal money pit
- The untapped potential of Qualified Longevity Annuity Contracts
- NYC's fiscal outlook on downslide over budget gaps
- Health insurance premium tax bill moving in Iowa House
More Advisor NewsAnnuity News
- Lincoln Financial launches two new FIAs
- Great-West Life & Annuity Insurance Company trademark request filed
- The forces shaping life and annuities in 2026
- Variable annuity sales surge as market confidence remains high, Wink finds
- New Allianz Life Annuity Offers Added Flexibility in Income Benefits
More Annuity NewsHealth/Employee Benefits News
- Portsmouth disputes $1.57 million SchoolCare health insurance bill
- Study Findings on Managed Care Are Outlined in Reports from First Medical Center (Economic burden of gastrointestinal malignancy among Medicare beneficiaries: A real-world cost-of-illness study): Managed Care
- Findings on Managed Care Reported by Researchers at University of Pennsylvania (Rising Home Care and Falling Wages: The Impact of the Growing Share of Home Care Workers on Direct Care Worker Wages): Managed Care
- Pennsylvania holds special Medicare enrollment period due to LVHN and United contract dispute
- Pennsylvania holds special Medicare enrollment period because of LVHN and UHC contract dispute
More Health/Employee Benefits NewsLife Insurance News
- Ethics and IUL: Tax-advantaged strategies for client success
- SWBC’s Joan Cleveland Appointed to the Texas Life and Health Insurance Guaranty Association Board of Directors
- Indexed life sales hit big despite lawsuits, market headwinds, Wink finds
- Are the biggest life insurance opportunities hiding during tax season?
- Hulse, Murray
More Life Insurance News